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Cyanide causes toxic effects by inhibiting cytochrome c oxidase,
resulting in cellular hypoxia and cytotoxic anoxia, and can eventually
lead to death. Cyanide exposure can be verified by direct analysis of
cyanide concentrations or analyzing its metabolites, including thiocyanate (SCN2) and 2-amino-2-thiazoline-4-carboxylic acid (ATCA)
in blood. To determine the behavior of these markers following cyanide exposure, a toxicokinetics study was performed in three animal
models: (i) rats (250 –300 g), (ii) rabbits (3.5–4.2 kg) and (iii) swine
(47–54 kg). Cyanide reached a maximum in blood and declined rapidly in each animal model as it was absorbed, distributed, metabolized and eliminated. Thiocyanate concentrations rose more slowly
as cyanide was enzymatically converted to SCN2. Concentrations
of ATCA did not rise significantly above the baseline in the rat
model, but rose quickly in rabbits (up to a 40-fold increase) and
swine (up to a 3-fold increase) and then fell rapidly, generally following the relative behavior of cyanide. Rats were administered cyanide
subcutaneously and the apparent half-life (t1/2) was determined to
be 1,510 min. Rabbits were administered cyanide intravenously and
the t1/2 was determined to be 177 min. Swine were administered
cyanide intravenously and the t1/2 was determined to be 26.9 min.
The SCN2 t1/2 in rats was 3,010 min, but was not calculated in rabbits and swine because SCN2 concentrations did not reach a maximum. The t 1/2 of ATCA was 40.7 and 13.9 min in rabbits and
swine, respectively, while it could not be determined in rats with confidence. The current study suggests that cyanide exposure may be
verified shortly after exposure by determining significantly elevated
cyanide and SCN2 in each animal model and ATCA may be used
when the ATCA detoxification pathway is significant.

Introduction
Cyanide (as HCN or CN2, represented inclusively as CN) is a rapidly acting, toxic chemical that can be readily absorbed by inhalation, ingestion or dermally. After CN is absorbed, it is rapidly
distributed throughout the body, causing toxic effects by
mechanisms that include inhibiting cytochrome c oxidase,
resulting in cellular hypoxia and cytotoxic anoxia, and can eventually result in death (1). Cyanide is volatile and reactive leading
to a short half-life (t1/2). It is difﬁcult to determine cyanide exposure by direct CN analysis if signiﬁcant time has elapsed (2 –
5). Thus, indirect biomarkers, including thiocyanate (SCN2)
and 2-amino-2-thiazoline-4-carboxylic acid (ATCA), are necessary in certain situations for the veriﬁcation of cyanide poisoning.

In the presence of a sulfur donor (e.g. thiosulfate) and a sulfur
transferase enzyme (e.g. rhodanese), 80% of a dose of CN is
metabolized to SCN2 (2 – 4, 6). Although SCN2 has been used
as the main indirect cyanide exposure marker, it can be difﬁcult
to establish deﬁnitive CN exposure due to large endogenous
SCN2 concentrations in biological ﬂuids (7 – 9). Cyanide can
also react with L-cystine through a proposed intermediate,
b-thiocyanoalanine, where it is subsequently transformed into
ATCA. ATCA is a minor metabolite of CN, and it has been suggested that it accounts for 15 –20% of cyanide metabolism (6,
10). ATCA may be useful as an alternative for determination of CN
exposure because it does not metabolize further (6, 11, 12), and
it is a chemically stable metabolite under most storage conditions
(13, 14). Although it is a promising marker of CN exposure, there
are relatively few studies on the behavior of ATCA following cyanide exposure, and the direct relationship between CN exposure
and elevated ATCA concentrations has only tenuously been
established (4, 14 –17).
The objective of the current study was to simultaneously determine the toxicokinetic behavior of CN, SCN2 and ATCA, providing a direct evaluation of the relationship between these
biomarkers. In addition, the ability of CN and its detoxiﬁcation
products to serve as cyanide exposure biomarkers was evaluated
and a comparison between multiple mammalian species was
performed.

Materials and Methods
Chemicals and samples
All chemicals used were at least HPLC grade or higher. Potassium
thiocyanate (KSCN), sodium cyanide (NaCN), sodium tetraborate
decahydrate and sodium hydroxide (NaOH) were all purchased
from Fisher Scientiﬁc (Fair Lawn, NJ, USA). Tetrabutylammonium
sulfate (TBAS; 50%, w/w, solution in water), used as a phase transfer catalyst, was purchased from Sigma-Aldrich (St. Louis, MO,
USA). Pentaﬂuorobenzyl bromide (PFB-Br) was obtained from
Thermo Scientiﬁc (Hanover Park, IL, USA). Isotopically labeled internal standards (NaS13C15N and Na13C15N) were acquired from
Isotech (Miamisburg, OH, USA). Solid-phase extraction (SPE)
MCX (mixed-mode cation exchange) columns were acquired
from Watersw Corporation (Milford, MA, USA). Deuterated ATCA
(ATCA-d2) was prepared by reaction of deuterated L-cysteine
(3,3-d2) with cyanamide (18) and provided by the Department
of Veterans Affairs Medical Center, Minneapolis, MN, USA.
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N-Methyl-N-trimethylsilyltriﬂuoroacetamide (MSTFA) was purchased from Pierce Chemical Company (Rockford, IL, USA).
Animals
Three different animal models were used in this study: (i)
Sprague-Dawley rats (Rattus norvegicus), (ii) New Zealand
White rabbits (Oryctologus cuniculus) and (iii) Yorkshire
swine (Sus scrofa). Male Sprague-Dawley rats weighing 250 –
300 g (Charles River Breeding Laboratories, Inc., Wilmington,
MA, USA) with catheters implanted were kept in temperature
and light-controlled rooms (22 + 28C, 12 h light/dark cycle),
fed Teklad Rodent Diet (W) 8604 (Teklad HSD, Inc., WI, USA)
and provided with water at Sam Houston State University
(Huntsville, TX, USA). Rabbits weighing 3.5 – 4.5 kg (Western
Oregon Rabbit Supply, Philomath, OR, USA) were housed individually in the Animal Resource Facility (ARF) of the College of
Medicine at the University of California, Irvine, CA, USA, fed
Purina Pro-lab (St. Louis, MO, USA) and provided with water.
Swine (47 –54 kg) were purchased from the local USDA licensed
breeder (John Albert, Cibolo, TX, USA, USDA #74-A-1246) and
were housed in paddocks (outdoor fenced pastures) and
moved into indoor pens before the experiments. They were furnished with Purina Pro-Lab’s (St. Louis, MO, USA) mini-pig-breeder
diet (5082) and provided with water.
All animals were cared for in compliance with the “Principles
of Laboratory Animal Care” formulated by the National Society
for Medical Research and the “Guide for the Care and Use of
Laboratory Animals” prepared by the National Academy of
Sciences and published by the National Institutes of Health
(NIH Publication #86 – 23, revised 1978). All studies involving
rats, rabbits or swine were reviewed and approved by the
Institutional Animal Care and Use Committee (IACUC) at the appropriate institutions.
Experimental design
Rats (N ¼ 9) were injected with sub-lethal doses (N ¼ 3) of potassium cyanide (KCN) solution subcutaneously [2 mg/kg (25%
LD50), 4 mg/kg (50% LD50) or 6 mg/kg (75% LD50)]. In order to
establish a baseline, blood was drawn prior to injection for a
“zero” time point. Blood samples (320 mL) were also drawn at
5, 15, 30, 60 min, and 2, 4, 6, 12, 15 and 50.5 h post-injection.
These blood samples were placed in heparinized tubes to prevent coagulation. The tubes were then centrifuged to separate
the plasma from the red blood cells (RBCs). A portion of plasma
was removed for ATCA analysis (50 mL) and the rest was hemolyzed to produce whole blood for simultaneous CN and SCN2
analysis. The baseline concentration for CN, SCN2 and ATCA in
saline-treated rats showed no signiﬁcant change in the concentration over the duration of the experiment.
New Zealand White rabbits (N ¼ 8) were anesthetized with an
intramuscular injection of a 2:1 ratio of ketamine HCl (100 mg/mL,
Ketaject, Phoenix Pharmaceutical Inc., St. Joseph, MI, USA): xylazine (20 mg/ml, Anased, Lloyd Laboratories, Shenandoah, IA,
USA) at a dose of 0.75 cc/kg. After the intramuscular injection,
a catheter was placed in the animals’ marginal ear vein to administer continuous IV ketamine/xylazine anesthesia. The animals
were intubated and were mechanically ventilated (dual phase
control respirator, model 32A4BEPM-5R, Harvard Apparatus,
Chicago, IL, USA) at a respiratory rate of 32 min21, a tidal volume

of 50 cc, and FiO2 of 100%. Blunt dissection was performed to
isolate the femoral artery and vein on the left thigh for cyanide
infusion and blood sampling. Sodium cyanide (10 mg) dissolved in
60 mL of 0.9% NaCl was administered intravenously through the
femoral line over 60 min. Blood samples (300 mL) were drawn at
11 different time points, including a baseline (time “zero”), 20, 40
and 55 min during CN infusion. After the cyanide infusion was
completed, seven additional time points over the next 90 min
at 60, 65, 75, 90, 105, 120 and 150 min from the start of the experiment were drawn. Arterial blood samples were collected in
heparinized tubes kept on ice and centrifuged to separate the
plasma. The plasma samples (150 mL) were then immediately frozen and shipped on ice to South Dakota State University (SDSU)
for analysis of CN, SCN2 and ATCA. The baseline concentration
for CN, SCN2 and ATCA in control saline-treated rabbits showed
no signiﬁcant change over the duration of the experiment. At the
completion of the experiment, the animals were euthanized with
an intravenous injection of 1.0 cc Euthasol (390 mg pentobarbital sodium, 50 mg phenytoin sodium; Vibrac AH, Inc, Fort
Worth, TX, USA) administered through the marginal ear vein.
Swine (N ¼ 11) were infused intravenously with approximately (or an average of ) 1.7 mg/kg potassium cyanide until apnea
occurred. The animals were then observed for an additional
60 min. Arterial blood (20 mL) was sampled prior to cyanide exposure (considered baseline or time ‘zero’), 5 min after the start
of the cyanide infusion, 5 min into cyanide administration, at
apnea and every 2 min for the ﬁrst 10 min after apnea, and
then every 10 min until 60 min postapnea. Blood (4 mL) was
placed in an EDTA tube and centrifuged to separate the plasma.
The plasma samples (500 mL) were then frozen and shipped on
ice to SDSU for analysis of CN, SCN2 and ATCA.
CN and SCN 2 analysis
The whole blood samples from rats and plasma samples from rabbits and swine were simultaneously analyzed for CN and SCN2 by
chemical-ionization (CI) GC – MS after chemical modiﬁcation
based on a method previously reported (19). Brieﬂy, blood samples (100 mL) were added to 2 mL microcentrifuge vials. Internal
standards (100 mL) of Na13C15N (200 mM) and NaS13C15N
(100 mM) were added to the sample vials along with TBAS
(800 mL of 10 mM TBAS in a saturated solution of sodium tetraborate decahydrate, pH 9.5) and PFB– Br (500 mL of a 20-mM solution in ethyl acetate) and vortexed for 2 min. Samples were
then heated at 708C for 1 h, and centrifuged for 4 min at
10,000 rpm (9,300  g) to separate the organic and aqueous
layers. The organic layer (200 mL) was collected and analyzed
using CI – GC – MS. The concentrations for both CN and SCN2
were well above the detection limit of the analytical method
(1 mM for CN and 50 nM for SCN2) for all samples analyzed.
ATCA analysis
Rat, rabbit and swine plasma samples (50 mL) were analyzed for
ATCA according to a slightly modiﬁed procedure previously
reported (20). Brieﬂy, plasma samples (80 mL), internal standard
(ATCA-d2; 120 mL of 100 ng/mL) and 300 mL of 1% HCl in acetone were added to a 2-mL microcentrifuge vial, vortexed for
2 min and centrifuged for 4 min (room temperature) at
10,000 rpm (9,300  g). The supernatant was transferred to a
clean microcentrifuge tube, 1.0 mL of 0.1 M HCl was added,
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and the sample was aspirated through a prepared mixed-mode
cation-exchange solid-phase extraction column (1 mL). The
ATCA was eluted from the column into a 2-mL microcentrifuge
tube using 1 mL of a water:methanol:ammonium hydroxide solution (25:50:25, by volume). Hydrochloric acid (200 mL of 0.1 M)
was added to the microcentrifuge tube to decrease the pH of the
sample ( pH , 11) and the sample was dried. The dried samples
were reacted with 200 mL of 30% MSTFA in hexane for 60 min at
50 8C in capped centrifuge tubes. The samples were then analyzed using electron-ionization GC – MS. The concentrations for
ATCA were well above the detection limit of the analytical
method (170 nM) for each plasma sample tested.

Toxicokinetic analysis
The blood and plasma concentration–time data after subcutaneous or intravenous administration were analyzed using a onecompartment toxicokinetic model which was determined
according to the methods previously described (21, 22).
Concentration – time curves were used to obtain the maximum
concentration (Cmax) of CN, SCN2 and ATCA in blood and
plasma, elimination constants (Kel ) and terminal elimination halflife (t1/2), with interpolation. A linear trapezoidal method was
used to calculate the area under the curve (AUC) for cyanide
and ATCA. The parameters such as Cmax, Kel, t1/2 and AUC were
not calculated for thiocyanate in rabbit and swine models because there was no elimination observed from these experimental subjects throughout the duration of the experiments. The
data presented is normalized to the baseline concentration of
each compound to allow variation in concentrations of the analytes evaluated (CN, SCN2 and ATCA) to be observed on the same

ﬁgure, such that direct comparison of the relative behavior can
more easily be observed.

Results
Behavior of CN, SCN 2 and ATCA following cyanide
exposure in Rats
Figure 1 shows the normalized CN, SCN2 and ATCA concentrations (i.e., normalized to the baseline concentration of the each
compound, listed in Table II) from rats dosed at 6 mg/kg KCN.
The baseline concentrations were determined to be 9.95, 38.6
and 0.282 mM for CN, SCN2 and ATCA, respectively. As seen in
Figure 1, the blood CN concentrations increased rapidly upon
subcutaneous injection of KCN to a maximum at 30 min and
then declined rapidly as cyanide was distributed and metabolized. The CN concentrations then leveled off at 100 min postexposure and slowly declined. Thiocyanate concentrations rose
at a slower rate compared with CN and then declined slowly at a
rate similar to that of cyanide after reaching a maximum at
120 min postexposure. Thiocyanate concentrations remained
well above baseline for the duration of the experiment.
Considering the variability of the data, ATCA concentrations
changed only slightly when compared with the baseline concentration. Similar trends for all markers were observed for each
dose of cyanide.

Dose– concentration behavior
The dose –blood concentration relationship for CN and SCN2 in
rats with the Cmax plotted for each dose is shown in Figure 2. As
the dose of KCN increased, there was an expected increase in

Figure 1. Whole blood CN, SCN2 and plasma ATCA normalized concentrations after cyanide exposure (6 mg/kg body weight KCN injection subcutaneously to rats). Error bars are
plotted as standard error of mean (SEM) (N ¼ 3). Inset: Full time course up to 50.5 h post-injection of KCN.
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Figure 3. Plasma CN, SCN2 and ATCA normalized concentrations after 10 mg NaCN
infusion to rabbits. Error bars are plotted as standard error of mean (SEM) (N ¼ 8).
Figure 2. Dose–concentration curve for three different doses of KCN (2, 4 and 6 mg/kg)
injected subcutaneously to rats. Error bars are plotted as standard error of mean (SEM)
(N ¼ 3).

the concentrations of CN and SCN2. Cyanide concentrations
showed a linear response to increasing CN dose, whereas the
dose – response of thiocyanate was non-linear, leveling off at
160 mM, with the 4 mg/kg dose and remaining at that level for
the 6 mg/kg dose. The dose response of ATCA was not meaningful
because of the large interanimal variability of plasma ATCA concentrations combined with the minor increase in Cmax compared
with baseline concentrations.
Behavior of CN, SCN 2 and ATCA in rabbits after cyanide
exposure
Figure 3 shows the normalized plasma concentrations of CN,
SCN2 and ATCA from rabbits (N ¼ 8) over 150 min. The baseline
concentrations were determined to be 5.66, 9.99 and 0.227 mM
for CN, SCN2 and ATCA, respectively. Plasma CN and ATCA concentrations reached a maximum at 55 min (14.7 and 9.1 mM for
CN and ATCA, respectively) and then declined after CN administration was stopped. Plasma SCN2 rose slowly throughout the
duration of the experiment (150 min). CN, SCN2 and ATCA
were measurable throughout the study. ATCA concentrations
clearly rose above the baseline by a larger ratio than the CN or
SCN2.
Behavior of CN, SCN 2 and ATCA after cyanide exposure
in swine
Figure 4 shows the normalized CN, SCN2 and ATCA concentrations from swine (N ¼ 11) over 40 min. The baseline concentrations were determined to be 3.87, 5.45 and 0.175 mM for CN,
SCN2 and ATCA, respectively. Plasma CN and ATCA concentrations reached a maximum at apnea (i.e., the 10-min time point)
and then declined. The concentrations of each metabolite normalized to the baseline are very similar until 4 min postapnea
(i.e., the 14 min time point in Figure 4) where the CN and

Figure 4. Swine plasma CN, SCN2 and ATCA normalized concentrations during and
after intravenous dose (0.17 mg/kg/min until apnea; 10 min). Error bars are
plotted as standard error of mean (SEM) (N ¼ 11).

ATCA continue to decrease, but the SCN2 rises slowly through
the completion of the experiment (40 min).
Toxicokinetics of CN, SCN 2 and ATCA
A summary of the toxicokinetic parameters for rats, rabbits and
swine is presented in Table I. The AUC, Cmax and t1/2 were calculated for all three markers of cyanide exposure with the exception of SCN2 in rabbits and swine because it did not reach a
maximum, and ATCA in rats because of considerable variability
at each time point and the very low concentrations of ATCA measured. In rats, the AUC ranged from 6.53  104 to 7.74  104 and
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Table I
The Toxicokinetic Parameters of Cyanide, Thiocyanate and ATCA in Different Animal Models
Animals

Analyte

Matrix

Current study
Rats

Pigs

Rabbits

Goats
Humans

Cyanide
Thiocyanate
ATCA
Cyanide
Thiocyanate
ATCA
Cyanide
Thiocyanate
ATCA
Cyanide
Thiocyanate
Cyanide
Thiocyanate
ATCA

Cmax (mM)

CN dose (mg/kg)

Blood
Plasma
Plasma
Blood/plasmae
Plasma
Plasma
Plasma
Plasma
Plasma
Blood
Plasma
Blood
Plasma
Plasma

a

b

c

2,4,6

Previous study
1.0 (23), 3.0 (3)
1.0 (23), 3.0 (3)
N/A (16), 10.0 (17)
3.0 (3)
3.0 (3)
–
–
–
–
3.0 (3)
3.0 (3)
–
–
–

1.7

2.5

–
–
–
–
–

t1/2 (min)

Current study
a

b

51.7 , 59.8 , 68.8
100a,168b,158c
N/Ad
30.2
N/Af
4.70
14.7
N/Af
9.10
–
–
–
–
–

Previous study
c

25 (23), 89.0 (3)
877 (23), 58.1 (3)
4.91 (16), 2.82 (17)
57.5 (3)
42.8 (3)
–
–
–
–
93.5 (3)
55.2 (3)
–
–
–

Current study
a

b

Previous study
c

1200 , 1370 ,1510
2530a,2860b,3010c
N/Ad
26.9
N/Af
13.9
177
N/Af
40.7
–
–
–
–
–

14.1(23),38.4(3)
348 (3)
150 (16)
32.4 (3)
297 (3)
–
–
–
–
76.8 (3)
834 (3)
20– 60 (2, 27)
1440 –8640 (25, 26, 28, 29)
–

a

Results obtained from 2 mg/kg CN dose (11).
Results obtained from 4 mg/kg CN dose.
c
Results obtained from 6 mg/kg CN dose.
d
ATCA could not be evaluated due to interanimal variability.
e
Plasma was used for cyanide analysis in our study.
f
SCN2 did not reach maximum value in our study.
b

Table II
Endogenous blood CN or plasma SCN2 and ATCA concentrations from humans, rats, rabbits
and swine models
Analyte

CNa
SCN2b
b

ATCA

Humans
(mM)

0.02 –2.9
(4), 0.03 –
10 (5)
4.83 –
87.5 (4)
0.08 –
0.122 (4)

Rabbits (mM)

Swine (mM)

Current
study

Rats (mM)
Previous
studies

Current
study

Previous
studies

Current
study

Previous
studies

10.78

0.19 (28, 40),
3.27 (29, 41)

5.61

3.84 (39)

8.82

N/A

42.91

53.0
20.0
0.96
1.29

8.64

N/A

8.17

0.23

N/A

1.51

17.1 (3),
41.1 (38)
N/A

0.64

(23),
(3)
(16),
(17)

a

CN analyzed from whole blood.
SCN2 and ATCA were commonly analyzed from plasma.

b

2.27  104 to 3.07  104mM min for cyanide and thiocyanate,
respectively. For rabbits, the AUC was found to be 0.33  104
and 548 mM min for cyanide and ATCA, respectively. The AUC
for swine was determined to be 0.05  104 and 75.4 mM min
for cyanide and ATCA, respectively.

Discussion
The toxicokinetic parameters found for CN, SCN2 and ATCA in
this study are presented in Table I, alongside similar studies for
comparison. Previously, cyanide has been found to be rapidly
absorbed, distributed and subsequently quickly eliminated
(2, 3, 23, 24), with a t1/2 ranging from 14 to 60 min. Rapid distribution of CN was also seen in our study for each model tested
(Figures 1, 3 and 4). For the rabbits and swine, CN was also rapidly eliminated, with t1/2 values of 27 and 178 min, which is in
general agreement with similar studies (Table I). Conversely, rats
produced a much longer mean elimination half-life. The difference may be due to the duration of our study, 50.5 h post
cyanide-exposure versus 1 and 24 h in the Leuschner et al.
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(23) and Sousa et al. (3) studies, respectively. If the three distribution/elimination time points in our study (i.e., 30, 60 and
120 min) are used, the half-life obtained (t1/2 ¼ 103 min) is comparable with that seen by Sousa et al. (3), and perhaps is more
reﬂective of cyanide distribution than elimination. In addition,
the other studies used oral dosing versus subcutaneous injection
in the rat model for our study. Subcutaneous injection could potentially cause a rapid absorption and distribution of CN, versus a
slower uptake of CN through the digestive tract. If a large dose of
cyanide was rapidly absorbed into the erythrocytes, as suggested
by Lundquist et al. (25), our data would suggest that the sequestered CN is only slowly released back into rat plasma for transport
to tissues to be metabolized. Whole blood concentrations were
also measured in multiple samples from each individual animal
for the duration of the current study versus multiple animals at
each time point in previous studies (3, 23). The ﬂuid volume
removed from an individual rat was 10% of the total body
ﬂuid volume. Thus, by the end of the experiment, despite
being provided with food and water ad lib, our experimental
subjects could have become dehydrated, causing their hematocrit to be elevated, potentially resulting in a higher level of CN
to be measured at later time points. Further investigations
would need to be conducted in the rat model to verify the prolonged half-life seen in this study. If veriﬁed, the long half-life may
indicate the ability of rats to tolerate elevated levels of CN over
long periods of time, perhaps due to a relatively large pool of sequestrating agents (e.g., methemoglobin). A relatively large pool
of sequestrating agents may reduce the free CN, thereby not
overwhelming normal detoxiﬁcation pathways leading to
increased tolerance of CN.
Thiocyanate in the swine and rabbits increased at about the
same rate as CN, while the formation of SCN2 in rats was markedly slower, which could be due to the method of CN administration, subcutaneous versus intravenous. At each dose, the
maximum concentration of thiocyanate in rats occurred at
around 1 h after cyanide exposure and stayed relatively consistent for several hours before it began to decrease. The extended

consistent SCN2 concentrations could be interpreted as having
reached a steady-state between formation and elimination of
thiocyanate. The mean elimination half-life of SCN2 in rats ranged from 2530 to 3010 min, and was much longer than that
was found in the Sousa et al. (2003) study, possibly due to the
reasons previously presented. That being said, the half-life of
SCN2 in rats did fall within the range of human SCN2 t1/2
(Table I).
Thiocyanate concentrations were still increasing at the end of
the rabbit and swine studies, and would be expected to peak and
decline as observed in rats if these studies were lengthened. It is
interesting to note that SCN2 declined immediately after apnea
in swine (i.e., after KCN administration was stopped), and then
started to rise slowly after the 6-min postapnea time point and
continued to rise for the duration of the study (Figure 3). This
behavior, which is atypical compared with other similar studies,
is likely inﬂuenced by several factors. Initially, plasma SCN2 levels
rose at about the same rate as the infused cyanide levels, reaching
a maximum at apnea, suggesting a direct correlation between
cyanide and thiocyanate levels. Then the plasma SCN2 declined
abruptly, possibly due to reduced cardiac output leading to lower
cyanide delivery to the detoxiﬁcation sites and reduced export of
thiocyanate due to lack of blood ﬂow in tissues. After several minutes of reduced SCN2 production and transport, the levels of
SCN2 increased, until the end of the experiment, albeit at a
slower rate than initially. The secondary rise in thiocyanate production would suggest that once the initial shock of apnea
passes, the SCN2 detoxiﬁcation pathway is reinitiated, although
the slower rate of SCN2 production might suggest some impairment in this process. If any portion of the CN transport or biotransformation is energy-dependent, the pathway might become
partially disabled by undergoing apnea. If the swine study were
to be lengthened in time, the SCN2 concentrations should
reach a maximum and decline, as observed in the rat study.
Compared with cyanide and thiocyanate, ATCA had the lowest
mean elimination half-life in rabbit and swine models, resulting in
shorter residence time in the plasma (Table I). In the rabbit and
swine models, ATCA generally mimicked the behavior of CN, but
appears to be a minor metabolic pathway for cyanide detoxiﬁcation, especially in rats. Although the general behavior of CN and
ATCA in each model is similar, the difference in the behavior of
normalized ATCA concentrations in rabbits (i.e., the 40-fold increase above baseline), compared with swine and rats (i.e., only
a 4-fold increase), is striking.
To investigate the likelihood of a minimized sulfur-donor cyanide detoxiﬁcation pathway causing increased production of
ATCA in rabbits, species-dependent rhodanese concentrations
in multiple animal tissues (e.g., liver, kidney, lung, brain, stomach
and muscle) were evaluated from literature sources. Among all
the tissues, kidney contains relatively large amounts of rhodanese: 6.69, 24.9, 10.44 – 110.8 and 6.20 – 7.69 mg/g tissue in
humans, swine, rats and rabbits, respectively (6, 26, 30, 31).
The lower rhodanese concentrations in humans and rabbits suggest that the sulfur donor pathway for cyanide detoxiﬁcation may
be less active when compared with swine and rats, potentially
leading to increased ATCA formation. L-Cystine concentrations
were also evaluated with only a few studies reporting liver concentrations ranging from 22 to 77 and 20 to 300 nmol/g tissue in
humans and rats, respectively (32, 33). Because the ranges of
L -cystine from these studies are similar, it is unclear as to if

L-cystine

concentrations play a role in the formation of ATCA as
opposed to thiocyanate. Further characterization of L-cystine
levels may shed some light on this hypothesized explanation of
elevated ATCA in rabbits.
As seen in Figure 2, cyanide exhibited a linear relationship
between the cyanide dose and blood concentrations under the
conditions tested, which fundamentally implies that cyanide
has rapid and complete distribution, with ﬁrst-order kinetic behavior. For SCN2, the dose–concentration behavior was non-linear
and as the dose of cyanide was increased, the plasma concentration of SCN2 initially increased to 4 mg/kg where it remained
essentially constant. This is likely due to saturation of the sulfurdonor pathway for cyanide detoxiﬁcation. As mentioned here
previously, the ATCA concentration – dose behavior was not
evaluated due to the large interanimal variability of plasma
ATCA concentrations in rats. This is an area of potential future
study likely best investigated in rabbits.
The percentage of cyanide converted to ATCA in this study
was estimated for rats, rabbits and swine. Cyanide conversion
to ATCA was calculated as a percentage by dividing the maximum
concentration of ATCA in each model over the total maximum
concentration of cyanide, thiocyanate and ATCA. Considering
that cyanide is distributed in the range of 70 – 96% in the red
blood cells, with the remainder in the plasma (25, 34), it was estimated that 0.10 – 0.78%, 2.46 – 9.19% and 0.60 – 3.7% of the
cyanide dose was converted to ATCA in rats, rabbits and swine,
respectively. Although the calculation of the percentage of cyanide conversion to ATCA from the current study is meant to be a
rough estimate and further studies should be undertaken to accurately determine the amount of cyanide converted to ATCA,
our calculations are signiﬁcantly lower than previously reported
estimates of 15 – 20% (6) and are likely even overestimated for
swine and rabbits, due to SCN2 failing to reach a maximum.
This difference is likely due to differences in experimental protocols, where Wood and Cooley (6) initially administered 20 mg
of L-cystine-S35 via tail vein, and after 15 and 25 min, 1 mg of
NaCN was subcutaneously administered. The added L-cystine potentially artiﬁcially increased the amount of ATCA generated.
It is well known that all biological samples contain endogenous concentrations of cyanide and its metabolites (4, 35 – 38).
Therefore, these concentrations were measured in each animal
prior to cyanide exposure and are reported in Table II, alongside
previous applicable work. In comparing the endogenous concentrations of CN, SCN2 and ATCA, the concentrations found in rabbits are closer to those found in humans than the rats and swine.
Conclusion
If kidney rhodanese and endogenous cyanide concentrations are
indicators of similarity between human and animal cyanide metabolism, the rabbits would be more similar to humans than rat
and swine. If the rabbit model approximates human behavior,
ATCA appears to be a promising candidate for early diagnosis
of cyanide poisoning. Speciﬁcally, ATCA shows similar behavior
relative to cyanide, it increases 40-fold above baseline concentrations, does not metabolize further (11, 14, 39) and it is exceedingly stable during storage of plasma samples (14, 20), something
that is a serious issue for CN and SCN2 (4, 19). Although the rabbit model appears to be the closest to humans in a number of indirect measurements, future work should address the absorption,
Cyanide Toxicokinetics 223

distribution and elimination of ATCA in humans (e.g., from nitroprusside patients) in parallel with rabbits in order to conﬁrm applicability of the rabbit to investigate human cyanide metabolism.
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